Evidence map›Paper›PMID 39885154›Full record

ArticleNature communications2025

Biocatalytic enantioselective formation and ring-opening of oxetanes.

Xia Hua, Yuan-Fei Wang, Xiao Jin, Hong-Yin Yu, Hui-Hui Wang, Yong-Zheng Chen, Nan-Wei Wan

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xia Hua *School of Pharmacy, Zunyi Medical University, Zunyi, 563000, China.
Yuan-Fei Wang *School of Pharmacy, Zunyi Medical University, Zunyi, 563000, China.
Xiao JinSchool of Pharmacy, Zunyi Medical University, Zunyi, 563000, China.
Hong-Yin YuSchool of Pharmacy, Zunyi Medical University, Zunyi, 563000, China.
Hui-Hui WangSchool of Pharmacy, Zunyi Medical University, Zunyi, 563000, China.
Yong-Zheng ChenSchool of Pharmacy, Zunyi Medical University, Zunyi, 563000, China.ORCID http://orcid.org/0000-0003-1211-3486
Nan-Wei WanSchool of Pharmacy, Zunyi Medical University, Zunyi, 563000, China. nanweiwan@zmu.edu.cn.ORCID http://orcid.org/0000-0003-3561-8380

Funding

National Natural Science Foundation of China (National Science Foundation of China) 32401047
6 · The paper itself

Abstract

Although biocatalysis offers complementary or alternative approaches to traditional synthetic methods, the limited range of available enzymatic reactions currently poses challenges in synthesizing a diverse array of desired compounds. Consequently, there is a significant demand for developing novel biocatalytic processes to enable reactions that were previously unattainable. Herein, we report the discovery and subsequent protein engineering of a unique halohydrin dehalogenase to develop a biocatalytic platform for enantioselective formation and ring-opening of oxetanes. This biocatalytic platform, exhibiting high efficiency, excellent enantioselectivity, and broad scopes, facilitates the preparative-scale synthesis of chiral oxetanes and a variety of chiral γ-substituted alcohols. Additionally, both the enantioselective oxetane formation and ring-opening processes are proven scalable for large-scale transformations at high substrate concentrations, and can be integrated efficiently in a one-pot, one-catalyst cascade system. This work expands the enzymatic toolbox for non-natural reactions and will promote further exploration of the catalytic repertoire of halohydrin dehalogenases in synthetic and pharmaceutical chemistry.

Indexed as

BiocatalysisEthers, CyclicHydrolasesAlcoholsProtein EngineeringStereoisomerismSubstrate SpecificityAlcoholsEthers, Cyclichalohydrin dehalogenaseHydrolasesoxetane

Identifiers

PMID39885154
PMCPMC11782660

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.